Procedures Cosmetic Dentistry Sedation Dentistry Photo Gallery About Us Contact Us
Procedures
Cosmetic Dentistry
Sedation Dentistry
Preventative Dentistry
Dental Problems
General Dentistry
Treatment
Special Offers
Make an Appointment with Dr. Scott Breazeale DMD Today
 Call: 228.896.7022
 Online Form: Click Here
 Email: Click Here

ViziLite System

ViziLite Plus with TBlue630 is an oral lesion identification and marking system that is used as an adjunct to the conventional head and neck examination. It is comprised of a chemiluminescent light source (ViziLite) to improve the identification of lesions and a blue phenothiazine dye to mark those lesions identified by ViziLite. ViziLitePlus with TBlue630 is designed to be used in a patient population at increased risk for oral cancer.
ViziLite Oral Lesion Identification System
In clinical trials involving 13,000 female patients, abnormal squamous epithelium in the cervical complex appears acetowhite after rinsing with a dilute acetic acid solution. Similarly in the oral cavity, after rinsing with a dilute acetic acid solution, abnormal squamous epithelium tissue will appear acetowhite when viewed under ViziLite's diffuse low-energy wavelength light. Normal epithelium will absorb the light and appear dark. ViziLite can assist a dentist or hygienist in identifying an abnormality in the oral cavity.
TBlue630 Oral Lesion Marking System
TBlue630 is a patented, pharmaceutical-grade toluidine blue-based metachromatic dye. It is used to further evaluate and closely monitor changes in ViziLite-identified lesions. It has been proposed that living cells will differentially accumulate toluidine blue based on parameters related to metabolic activity. TBlue630, packaged in an easy to use 3-swab system, provides the deep blue staining that allows ViziLite-identified lesions to be seen clearly under normal light.
Why it is Important?
Your patients rely on you to be an expert in oral health. Dentists and hygenists are the best overall defense against oral cancer - they are, in fact, lifesavers. No other medical professionals are as well positioned to address this potentially deadly disease at its earliest stage. The key is to identify oral abnormalities at their most easily treated stage of development.
Fortunately, there's a simple technology to help in your fight against oral cancer. ViziLite Plus aids in the early identification of oral abnormalities that can lead to cancer. Cleared by the FDA, ViziLite Plus allows Dr. Breazeale to offer superior care to his patients. Annual ViziLite Plus exams can be integrated with existing patient services and improve patient care.
ViziLite Plus Oral Screening Protocol
As is the case with most cancers, age is the primary risk factor for oral cancer. Approximately 90% of oral cancer victims are age 40 and older, recent studies indicate that increasingly, patients younger than age 40 are being diagnosed with oral cancer. Though tobacco and alcohol use are the primary lifestyle risk factors that contribute to the development of oral cancer, 27% of oral cancer victims do not use tobacco or alcohol, and have no lifestyle risk factors. Oral cancer affects men more than women, 2:1, but oral cancer in women is on the rise nationwide.
Patients with a history of oral cancer should receive at least semi-annual ViziLite Plus exams.

228.896.7022 

430 Security Square, Gulfport, MS  39507
Dr. Scott Breazeale2018. All Rights Reserved. Site created and maintained by RAMP Sites
Gulfport ViziLite Dentist MS Gulf Coast Dr. Breazeale Cosmetic & Family Dentistry 228.896.7022 - ViziLite Plus with TBlue630 is an oral lesion identification and marking system that is used as an adjunct to the conventional head and neck examination.